The Metric That People May Not Have Heard Of, but at Is Really Vital to the Future of Vacian Development

18sec Snip

00:00

Play full episode

Summary

Transcript

Episode notes

The metric that people may not have heard of, but at is really vital to the future of vacian development. This is certainly something we're oingto be watching moving forward, as studies come out. But for now, you and thank you so much. It's been really great to have you on. I hope to speak to you soon. Ye, thanks.

Since the beginning oft he pandemic, researchers have searched for a biomarker which indicates immune protection from COVID-19 known as a correlate of protection. Now, the team developing the Oxford–AstraZeneca COVID-19 vaccine have published the first results of their so-called 'breakthrough study' which indicated puts forwards thresholds of neutralising antibodies that they suggest correlate with protection. The hope is that, should these results be confirmed, such biomarkers could speed up the development of new vaccines, and provide better ways to monitor the efficacy of tweaked vaccine aimed at fighting variants.

News: Scientists identify long-sought marker for COVID vaccine success

Subscribe to Nature Briefing, an unmissable daily round-up of science news, opinion and analysis free in your inbox every weekday.

Hosted on Acast. See acast.com/privacy for more information.